The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: -0.40 (-1.21%)
Spread: 1.40 (4.375%)
Open: 33.10
High: 33.20
Low: 32.70
Prev. Close: 33.10
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealings

5 Jan 2022 12:36

RNS Number : 5356X
Mercia Asset Management PLC
05 January 2022
 

RNS

5 January 2022

 

Mercia Asset Management PLC

 

("Mercia", the "Group" or the "Company")

 

Director/PDMR Dealings

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£948million of assets under management, announces that it has received notifications of the following transactions relating to Ordinary shares of £0.00001 each in the capital of Mercia ("Ordinary Shares") by Directors and PDMRs of the Company as follows:

 

· Mark Payton, Director and Chief Executive Officer of the Company, became beneficially interested in a further 12,793 Ordinary Shares. These shares were bought today at 38.10p per share by his spouse.

 

· Martin Glanfield, Director and Chief Financial Officer of the Company, became beneficially interested in a further 39,470 Ordinary Shares. The shares were bought today at 38.00p per share by his SIPP.

 

Following the above transactions, Messrs Payton and Glanfield are beneficially interested in the following number of Ordinary Shares:

Director/PDMR

Number of Ordinary Shares

Percentage of issued Ordinary share capital

Mark Payton*

7,021,604

1.60

Martin Glanfield**

1,466,887

0.33

*Including 12,793 Ordinary shares held by Katharine Yeo

**Including 125,784 Ordinary shares held by Bryonie Glanfield

 

The notifications below are made in accordance with the requirements of the Market Abuse Regulations.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Katharine Yeo

2

Reason for the notification

a)

Position / status

Person closely associated with Mark Payton, chief executive officer of Mercia Asset Management PLC

b)

Initial notification / amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

LEI

213800A1Q4CF57NECG66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.00001 each

ISIN: GB00BSL71W47

b)

 

Nature of the transaction

 

Acquisition of 12,793 Ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

38.10

12,793

d)

Aggregated information

- Aggregated volume

- Price

 

12,793

38.10

e)

Date of the transaction

5 January 2022, UK

f)

Place of the transaction

AIM (AIMX)

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Martin Glanfield

2

Reason for the notification

a)

Position / status

Director (PDMR)

b)

Initial notification / amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

LEI

213800A1Q4CF57NECG66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.00001 each

ISIN: GB00BSL71W47

b)

 

Nature of the transaction

 

Acquisition of 39,470 Ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

38.00

39,470

d)

Aggregated information

- Aggregated volume

- Price

 

39,470

38.00

e)

Date of the transaction

5 January 2022, UK

f)

Place of the transaction

AIM (AIMX)

 

-Ends-

 

For further information, please contact:

 

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Andrew Potts

Singer Capital Markets (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

+44 (0)20 3727 1051

Tom Blackwell, Louisa Feltes, Immy Ransom

mercia@fticonsulting.com

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet. 

 

The Group has a strong UK footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.£948million of assets under management and, since its IPO in December 2014, has invested c.£116million gross into its direct investment portfolio.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKPBNBBKDBDK
Date   Source Headline
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update
25th Mar 20201:42 pmRNSNotification of Major Holdings
18th Mar 202010:59 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Mar 20204:18 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSPDMR / Director Dealings
4th Feb 20208:50 amRNSNotification of Major Holdings
4th Feb 20207:00 amRNSHolding in Company
29th Jan 20207:00 amRNSGrant of Options
22nd Jan 202012:49 pmRNSForm 8.3 - RedX Pharma PLC
17th Jan 20204:45 pmRNSNotification of Major Holdings
16th Jan 20207:00 amRNSnDreams makes continuing commercial progress
9th Jan 20202:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jan 20202:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
31st Dec 201910:55 amRNSNotification of Major Holdings
30th Dec 201911:57 amRNSNOTIFICATION OF MAJOR HOLDINGS
30th Dec 201911:36 amRNSNOTIFICATION OF MAJOR HOLDINGS
27th Dec 201912:01 pmRNSNOTIFICATION OF MAJOR HOLDINGS
24th Dec 201912:16 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20193:36 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:14 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:04 pmRNSCompletion of Acquisition
23rd Dec 201912:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20199:49 amRNSDirector/PDMR Dealings
20th Dec 201910:29 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.